According to a WHO study, approximately 70 million people have been infected with the HIV virus, and 35 million have died as a result of HIV infection. With rising mortality, the government and non-government institutes are taking initiatives and providing funding for diagnostic treatment and prevention of HIV/AIDS. With the advancement of technology, novel diagnostic products are available on the market that requires minimum technical skills, such as portable cell counters and point-of-care rapid diagnostic tests that fasten the diagnosis process. In developing countries such as India and China, with a growing population and rising awareness about HIV, emerging economies will be lucrative markets for HIV/AIDS diagnostics. An increase in the incidence of HIV infection, awareness about HIV/AIDS diagnosis and treatment, and rising research and development for early diagnosis, treatment, and prevention are key factors driving the HIV/AIDS diagnostic market.
The report titled "HIV/AIDS Diagnostics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall HIV/AIDS diagnostics market, along with the market size and estimates for the duration of 2015–2025. The research study in question provides an in-depth examination of multiple market segments based on product type and geography. The product type segment studied for analyzing the overall global HIV/AIDS diagnostics market is majorly segmented into antibody tests, HIV-2 and Group-O diagnostic tests, viral load tests, CD4 testing, early infant diagnostics, and viral identification testing.
Geographically, the global HIV/AIDS diagnostics market is studied for the following regional markets:
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America (LATAM)
Mexico
Brazil
Rest of LATAM
Middle East and Africa (MEA)
Saudi Arabia
South Africa
the remainder of MEA
The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2016–2024 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global HIV/AIDS diagnostics market. Tools such as key player market positioning and an appealing investment proposition provide readers with insights into the global HIV/AIDS diagnostics market's competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global HIV/AIDS diagnostics market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.
Based on the type of products, the HIV/AIDS diagnostics market is segmented as follows:
Antibody Tests
HIV-1 screening tests
ELISA
Rapid Tests
Home Access: Dried Blood Spots
HIV-1 Antibody Confirmatory Tests
Western blot tests
Indirect Immunofluorescence Assays (IFA)
Line Immunoassays
Radio-Immunoprecipitation Assays
Viral identification testing
P24 Antigen
A Qualitative PCR Test
Viral Culture
HIV-2 and Group O Diagnostic Tests
Viral load tests
CD4 Testing
Early infant diagnostics
Antibody testing is the most commonly used test for detecting HIV infection. Technological advancement in screening tests, the rising incidence of HIV, and growing awareness about blood donation act as the major drivers of the antibody testing market. Rapid tests and ELISA form the major markets for HIV diagnostic tests. With technological advancements, confirmatory antibody tests have become extremely accurate in providing the end result; for example, a western blot test provides 100% accuracy in post-antibody test result screening. Thus, owing to their high accuracy rate and increase in usage, antibody tests will continue to occupy a dominant position in the forecast period. Monitoring tests such as viral load testing and CD4 testing, which are used to evaluate virologic load and assess the treatment's safety, are anticipated to be the fastest-growing market.
For the purpose of this study, the global HIV/AIDS diagnostics market is geographically categorized into:
North America (U.S. and Canada)
Europe (U.K., Germany, and the Rest of Europe)
Asia Pacific (China, Japan, and the Rest of APAC)
Latin America (Brazil, Mexico, and the Rest of Latin America)
Middle East and Africa (United Arab Emirates, Saudi Arabia, South Africa, the rest of the Middle East, and Africa)
In 2016, North America dominated the global HIV/AIDS diagnostics market, followed by Europe. In the North American region, the U.S. occupies the maximum share of the market due to the rise in the prevalence of HIV infection, growing awareness programs, health care access, and national funding for HIV-affected people. At the regional level, Canada has different programs for the treatment of AIDS, which further drives the diagnostic market in the country. Europe is the next important market, driven by factors such as convenient access to healthcare facilities, high healthcare spending, and the introduction of novel treatment opportunities. Asia Pacific is anticipated to have the fastest growth in the HIV/AIDS diagnostic market in the forecast period. Developing countries contribute to the rising number of HIV-AIDS populations, and along with an increase in government initiatives for HIV diagnostic and treatment facilities, rising healthcare expenditure further drives the diagnostic market for the Asia Pacific.
Frequently Asked Questions:
The market for HIV/AIDS Diagnostics is expected to reach US$ 8.718.8 Mn in 2024.
The HIV/AIDS Diagnostics market is expected to see significant CAGR growth over the coming years, at 9.4%.
The report is forecasted from 2016-2024.
The base year of this report is 2015.
Abbott Laboratories,Abbvie Inc.,Alere Inc.,Apogee Flow Systems,Beckman Coulter, Inc. are some of the major players in the global market.
